Now Credit Card Companies Want Your DNA
By Martha C. White,
Time: Moneyland
| 10. 27. 2011
A
Wall Street Journal article earlier this week reported that Visa and MasterCard are exploring new ways to take data about your buying habits in the brick-and-mortar world and let online marketers use that information to target you with ads when you browse the web. But buried a little ways down in the article are some details that are considerably more alarming. Visa, the article says, wants access to everything from your insurance claim history to your Facebook friends list to your DNA. Yes, you read that right:
According to a Visa patent application published in April, the company sees potential to use a wide array of personal details to create profiles that could be used for ad targeting well beyond shopping details. It describes the possibility of also using “information from social network websites, information from credit bureaus, information from search engines, information about insurance claims, information from DNA databanks,” and other sources.
This is a huge can of worms, warns Lillie Coney, associate director of the Electronic Privacy Information Center. “This is going to be problematic,” she says...
Related Articles
By Alondra Nelson, Science | 01.15.2026
One of the most interventionist approaches to technology governance in the United States in a generation has cloaked itself in the language of deregulation. In early December 2025, President Donald Trump took to Truth Social to announce a forthcoming “One...
By Daphne O. Martschenko and Julia E. H. Brown, Hastings Bioethics Forum | 01.14.2026
There is growing concern that falling fertility rates will lead to economic and demographic catastrophe. The social and political movement known as pronatalism looks to combat depopulation by encouraging people to have as many children as possible. But not just...
By Danny Finley, Bill of Health | 01.08.2026
The United States Food and Drug Administration (FDA) has a unique funding structure among federal scientific and health agencies. The industries it regulates fund nearly half of its budget. The agency charges companies a user fee for each application
...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...